文献速递角膜与眼表疾病青光眼

结膜伤口愈合中成纤维细胞的调控

Modulation of Fibroblasts in Conjunctival Wound Healing.
PubMed 文献 · Ophthalmology · 2017-11-01

本综述更新了当前抗纤维化药物的应用现状,并概述了新药从基础到临床所采用的策略,重点在于调控成纤维细胞增殖、分化、细胞外基质产生和凋亡,以改善青光眼滤过手术及眼瘢痕性类天疱疮、春季角结膜炎和翼状胬肉等疾病的结局。

要点

  • 抗炎药和抗代谢药已成功用于调控结膜伤口愈合,但为非特异性药物且并非没有并发症。
  • 调控成纤维细胞增殖、分化、细胞外基质产生和凋亡是控制结膜纤维化的靶向策略。
  • 本综述更新当前抗纤维化药物现状并概述新药从基础到临床的策略。

核心结论

  • 调控结膜伤口愈合有可能改善青光眼滤过手术后的结局以及眼瘢痕性类天疱疮、春季角结膜炎和翼状胬肉等多种眼部疾病的结局。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • 抗炎药和抗代谢药已成功用于调控结膜伤口愈合,但这些非特异性药物并非没有并发症。
  • 寻找新型且更具靶向性的控制结膜纤维化且无此类局限的方法,使调控成纤维细胞增殖、分化、细胞外基质产生和凋亡受到广泛关注。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Modulating conjunctival wound healing has the potential to improve outcomes after glaucoma filtration surgery and for several ocular disorders, including ocular cicatrial pemphigoid, vernal keratoconjunctivitis, and pterygium. Although anti-inflammatories and antimetabolites have been used with success, these nonspecific agents are not without their complications. The search for novel and more targeted means to control conjunctival fibrosis without such limitations has brought much attention to the regulation of fibroblast proliferation, differentiation, extracellular matrix production, and apoptosis. This review provides an update on where we stand with current antifibrotic agents and outlines the strategies that novel agents use, as they evolve from the bench to the bedside.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Zada M, Pattamatta U, White A, et al. Modulation of Fibroblasts in Conjunctival Wound Healing. Ophthalmology. 2017. PMID: 29079272. doi:10.1016/j.ophtha.2017.08.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。